NFIL3 Orchestrates the Emergence of Common Helper Innate Lymphoid Cell Precursors
Wei Xu,
Rita G. Domingues,
Diogo Fonseca-Pereira,
Manuela Ferreira,
Hélder Ribeiro,
Silvia Lopez-Lastra,
Yasutaka Motomura,
Lara Moreira-Santos,
Franck Bihl,
Véronique Braud,
Barbara Kee,
Hugh Brady,
Mark C. Coles,
Christian Vosshenrich,
Masato Kubo,
James P. Di Santo,
Henrique Veiga-Fernandes
Affiliations
Wei Xu
Innate Immunity Unit, Inserm U668, Institut Pasteur, 25 Rue du Docteur Roux, 75724 Paris, France
Rita G. Domingues
Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal
Diogo Fonseca-Pereira
Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal
Manuela Ferreira
Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal
Hélder Ribeiro
Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal
Silvia Lopez-Lastra
Innate Immunity Unit, Inserm U668, Institut Pasteur, 25 Rue du Docteur Roux, 75724 Paris, France
Yasutaka Motomura
Laboratory for Cytokine Regulation, Research Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute, Suehiro-cho 1-7-22, Tsurumi, Yokohama, Kanagawa 230-0045, Japan
Lara Moreira-Santos
Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal
Franck Bihl
Centre National de la Recherche Scientifique - UMR 7275 Institut de Pharmacologie Moléculaire et Cellulaire, 660 Route des Luciole, 06560 Valbonne, France
Véronique Braud
Centre National de la Recherche Scientifique - UMR 7275 Institut de Pharmacologie Moléculaire et Cellulaire, 660 Route des Luciole, 06560 Valbonne, France
Barbara Kee
Department of Pathology, University of Chicago, Chicago, IL 60637, USA
Hugh Brady
Department of Life Sciences, Imperial College, London SW7 2AZ, UK
Mark C. Coles
Centre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York YO10 5DD, UK
Christian Vosshenrich
Innate Immunity Unit, Inserm U668, Institut Pasteur, 25 Rue du Docteur Roux, 75724 Paris, France
Masato Kubo
Laboratory for Cytokine Regulation, Research Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute, Suehiro-cho 1-7-22, Tsurumi, Yokohama, Kanagawa 230-0045, Japan
James P. Di Santo
Innate Immunity Unit, Inserm U668, Institut Pasteur, 25 Rue du Docteur Roux, 75724 Paris, France
Henrique Veiga-Fernandes
Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal
Innate lymphoid cells (ILCs) are a family of effectors that originate from a common innate lymphoid cell progenitor. However, the transcriptional program that sets the identity of the ILC lineage remains elusive. Here, we show that NFIL3 is a critical regulator of the common helper-like innate lymphoid cell progenitor (CHILP). Cell-intrinsic Nfil3 ablation led to variably impaired development of fetal and adult ILC subsets. Conditional gene targeting demonstrated that NFIL3 exerted its function prior to ILC subset commitment. Accordingly, NFIL3 ablation resulted in loss of ID2+ CHILP and PLZF+ ILC progenitors. Nfil3 expression in lymphoid progenitors was under the control of the mesenchyme-derived hematopoietin IL-7, and NFIL3 exerted its function via direct Id2 regulation in the CHILP. Moreover, ectopic Id2 expression in Nfil3-null precursors rescued defective ILC lineage development in vivo. Our data establish NFIL3 as a key regulator of common helper-like ILC progenitors as they emerge during early lymphopoiesis.